News & Events
Veravas launched in 2017 with a mission that went far beyond just selling technology or building products. We want to impact healthcare, raising the bar for diagnostic accuracy, efficacy, and the scope of what can be tested.
Filter: News > Events > Webinars >
Saliva Diagnostics Webinar: Early Detection of Disease
Hosted by Josh Soldo [Veravas CSO and Co-Founder), this webinar will feature a panel of experts who will discuss the latest advances in this field and how they enable the use of saliva samples for biomarker detection.
Veravas is excited to host an upcoming webinar on techniques and methodologies for ultra sensitive saliva biomarker detection.
January 31, 2023
12pm EST / 11am CST / 9am PST
Event Details:
Hosted by Josh Soldo [Veravas CSO and Co-Founder), this webinar will feature a panel of experts who will discuss the latest advances in this field and how they enable the use of saliva samples for biomarker detection.
The panelists will discuss a variety of topics, including the different methods used for ultra sensitive biomarker detection, the benefits of using saliva samples, and the potential applications of this technology. They will also address common challenges and limitations in this field, and provide insights on how to overcome them.
Attendees of this webinar will have the opportunity to learn from leading experts and ask questions in real time. Whether you are a researcher, healthcare provider, or simply interested in learning more about this exciting topic, we encourage you to join us for this informative and engaging discussion.
Speakers:
Moderator:
Register:
Simplified removal of common interferences from serum and plasma using a novel Streptavidin based “Ninja” pre-analytical reagent
2021 Virtual Biopharma Symposium
Speaker:
Josh Soldo, Chief Scientific Officer and Co-Founder of Veravas
Immunoassay Interferences & Their Impact on Patient Care
In this session our industry experts review how the common immunoassay formats work, how the different types of interference mechanisms cause falsely elevated and suppressed results for each assay format, how these interferences may impact patient care and outcomes, and how current strategies are used to troubleshoot interference.
Presenters:
Nikola Baumann, PhD, DABCC, Co-Director Central Clinical Laboratory and Central Processing at Mayo Clinic in Rochester, MN
Brooke Katzman, PhD, DABCC, Co-Director of the Hospital Clinical Lab and Point of Care Testing at Mayo Clinic in Rochester, MN
Pr. Damien Gruson, PhD, EuSpLM, FESC, Chef du Service de Biochimie Médicale in Bruxelles – Belgique